ProCredit Holding AG & Co KGaA (PCZ)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 8.800 |
|---|---|
| 52-week range | 6.900 – 9.540 |
| Return, 1 month / 3 months | −1.3% / +5.5% |
| Return, 1 year / 3 years | −1.5% / +63.1% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 31.2% |
| Worst drawdown (1 year) | -25.8% |
| Average daily value traded | 0.37M EUR |
| Dividend yield | 5.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ProCredit Holding AG & Co KGaA is the parent of a group of development-oriented commercial banks that operate in Eastern and South-Eastern Europe and in parts of South America. The group's banks serve small and medium-sized businesses, providing business loans, working capital finance and investment credit, alongside savings accounts, deposits and payment services for private customers. The company is based in Frankfurt, Germany, where it coordinates the group's strategy and risk management.
ProCredit Holding AG & Co KGaA trades under the code PCZ on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ProCredit Holding AG & Co KGaA (PCZ) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 8.800 on 22 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 173 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.5% and over the last three months it rose 5.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -7.4% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.5% | ||
| 6-month return | 9.4% | ||
| 12-month return, skipping the last month | -0.2% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.8% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.37M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.3% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −1.3% |
| 3 months | +5.5% |
| 6 months | +9.4% |
| 1 year | −1.5% |
| 3 years | +63.1% |
| 5 years | +39.2% |
Signals
| 50-day / 200-day average | 8.684 / 8.078 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.218 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.4700 |
| 5 Jun 2025 | EUR 0.5900 |
| 5 Jun 2024 | EUR 0.6400 |
| 9 Dec 2021 | EUR 0.3500 |
| 28 May 2021 | EUR 0.1800 |
| 20 May 2019 | EUR 0.3000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.